175 related articles for article (PubMed ID: 31545250)
1. High Notch1 expression affects chemosensitivity of head and neck squamous cell carcinoma to paclitaxel and cisplatin treatment.
Zhang Z; Zhou Z; Zhang M; Gross N; Gong L; Zhang S; Lei D; Zeng Q; Luo X; Li G; Li X
Biomed Pharmacother; 2019 Oct; 118():109306. PubMed ID: 31545250
[TBL] [Abstract][Full Text] [Related]
2. Prognostic and chemotherapeutic implications of a novel four-gene pyroptosis model in head and neck squamous cell carcinoma.
Yuan P; Jiang S; Wang Q; Wu Y; Jiang Y; Xu H; Jiang L; Luo X
PeerJ; 2024; 12():e17296. PubMed ID: 38756442
[TBL] [Abstract][Full Text] [Related]
3. Antiproliferative efficacies but minor drug transporter inducing effects of paclitaxel, cisplatin, or 5-fluorouracil in a murine xenograft model for head and neck squamous cell carcinoma.
Theile D; Gal Z; Warta R; Rigalli JP; Lahrmann B; Grabe N; Herold-Mende C; Dyckhoff G; Weiss J
Cancer Biol Ther; 2014 Apr; 15(4):436-42. PubMed ID: 24448417
[TBL] [Abstract][Full Text] [Related]
4. Correlation of Notch1 expression and activation to cisplatin-sensitivity of head and neck squamous cell carcinoma.
Zhang ZP; Sun YL; Fu L; Gu F; Zhang L; Hao XS
Ai Zheng; 2009 Feb; 28(2):100-3. PubMed ID: 19550121
[TBL] [Abstract][Full Text] [Related]
5. The efficacy of induction chemotherapy with docetaxel, cisplatin and 5-fluorouracil combined with cisplatin concurrent chemoradiotherapy for locally advanced head and neck squamous cell carcinoma: a matched pair analysis.
Teo M; Karakaya E; Young CA; Dyker KE; Coyle C; Sen M; Prestwich RJ
Clin Oncol (R Coll Radiol); 2013 Nov; 25(11):647-53. PubMed ID: 23948462
[TBL] [Abstract][Full Text] [Related]
6. nab-Paclitaxel-based induction chemotherapy followed by cisplatin and radiation therapy for human papillomavirus-unrelated head and neck squamous-cell carcinoma.
Johnson KCC; Ley J; Oppelt P; Lu J; Gay HA; Daly M; Jackson R; Rich J; Pipkorn P; Paniello RC; Zevallos J; Thorstad W; Adkins DR
Med Oncol; 2019 Oct; 36(11):93. PubMed ID: 31595355
[TBL] [Abstract][Full Text] [Related]
7. Expression of Stat3 and Notch1 is associated with cisplatin resistance in head and neck squamous cell carcinoma.
Gu F; Ma Y; Zhang Z; Zhao J; Kobayashi H; Zhang L; Fu L
Oncol Rep; 2010 Mar; 23(3):671-6. PubMed ID: 20127005
[TBL] [Abstract][Full Text] [Related]
8. A triplet chemotherapy regimen of cisplatin, fluorouracil and paclitaxel for locoregionally recurrent nasopharyngeal carcinoma cases contraindicated for re-irradiation/surgery.
Wang Y; Wang ZQ; Jiang YX; Wang FH; Luo HY; Liang Y; Wang DS; Li YH
Expert Opin Pharmacother; 2016 Aug; 17(12):1585-90. PubMed ID: 27328125
[TBL] [Abstract][Full Text] [Related]
9. Notch1 signaling contributes to stemness in head and neck squamous cell carcinoma.
Lee SH; Do SI; Lee HJ; Kang HJ; Koo BS; Lim YC
Lab Invest; 2016 May; 96(5):508-16. PubMed ID: 26927514
[TBL] [Abstract][Full Text] [Related]
10. Notch1 regulates invasion and metastasis of head and neck squamous cell carcinoma by inducing EMT through c-Myc.
Inamura N; Kimura T; Wang L; Yanagi H; Tsuda M; Tanino M; Nishihara H; Fukuda S; Tanaka S
Auris Nasus Larynx; 2017 Aug; 44(4):447-457. PubMed ID: 27595504
[TBL] [Abstract][Full Text] [Related]
11. DL-Methadone as an Enhancer of Chemotherapeutic Drugs in Head and Neck Cancer Cell Lines.
Landgraf V; Griessmann M; Roller J; Polednik C; Schmidt M
Anticancer Res; 2019 Jul; 39(7):3633-3639. PubMed ID: 31262889
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of Notch1 increases paclitaxel sensitivity to human breast cancer.
Zhao L; Ma Y; Gu F; Fu L
Chin Med J (Engl); 2014; 127(3):442-7. PubMed ID: 24451948
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of drug transporters' significance for multidrug resistance in head and neck squamous cell carcinoma.
Theile D; Ketabi-Kiyanvash N; Herold-Mende C; Dyckhoff G; Efferth T; Bertholet V; Haefeli WE; Weiss J
Head Neck; 2011 Jul; 33(7):959-68. PubMed ID: 20737486
[TBL] [Abstract][Full Text] [Related]
14. Significance of mammalian target of rapamycin in patients with locally advanced stage IV head and neck squamous cell carcinoma receiving induction chemotherapy with docetaxel, cisplatin, and fluorouracil.
Li SH; Lin WC; Huang TL; Chen CH; Chiu TJ; Fang FM; Huang WT; Hsu CM; Luo SD; Lai CC; Su YY; Chuang HC; Chien CY
Head Neck; 2016 Apr; 38 Suppl 1():E844-52. PubMed ID: 25917382
[TBL] [Abstract][Full Text] [Related]
15. Docetaxel, cisplatin, and fluorouracil for patients with inoperable recurrent or metastatic head and neck squamous cell carcinoma.
Cho H; Nishiike S; Yamamoto Y; Takenaka Y; Nakahara S; Yasui T; Hanamoto A; Inohara H
Auris Nasus Larynx; 2015 Oct; 42(5):396-400. PubMed ID: 25721854
[TBL] [Abstract][Full Text] [Related]
16. Induction chemotherapy followed by concurrent radio-chemotherapy versus concurrent radio-chemotherapy alone as treatment of locally advanced squamous cell carcinoma of the head and neck (HNSCC): A meta-analysis of randomized trials.
Budach W; Bölke E; Kammers K; Gerber PA; Orth K; Gripp S; Matuschek C
Radiother Oncol; 2016 Feb; 118(2):238-43. PubMed ID: 26589131
[TBL] [Abstract][Full Text] [Related]
17. Silencing of high-mobility group box 2 (HMGB2) modulates cisplatin and 5-fluorouracil sensitivity in head and neck squamous cell carcinoma.
Syed N; Chavan S; Sahasrabuddhe NA; Renuse S; Sathe G; Nanjappa V; Radhakrishnan A; Raja R; Pinto SM; Srinivasan A; Prasad TS; Srikumar K; Gowda H; Santosh V; Sidransky D; Califano JA; Pandey A; Chatterjee A
Proteomics; 2015 Jan; 15(2-3):383-93. PubMed ID: 25327479
[TBL] [Abstract][Full Text] [Related]
18. Examination of the optimal condition on the in vitro sensitivity to telomelysin in head and neck cancer cell lines.
Sakakibara A; Tsukuda M; Kondo N; Ishiguro Y; Kimura M; Fujita K; Takahashi H; Matsuda H
Auris Nasus Larynx; 2011 Oct; 38(5):589-99. PubMed ID: 21362583
[TBL] [Abstract][Full Text] [Related]
19. A phase II evaluation of a 3-hour infusion of paclitaxel, cisplatin, and 5-fluorouracil in patients with advanced or recurrent squamous cell carcinoma of the head and neck: Southwest Oncology Group study 0007.
Worden FP; Moon J; Samlowski W; Clark JI; Dakhil SR; Williamson S; Urba SG; Ensley J; Hussain MH;
Cancer; 2006 Jul; 107(2):319-27. PubMed ID: 16779801
[TBL] [Abstract][Full Text] [Related]
20. HEY1 is expressed independent of NOTCH1 and is associated with poor prognosis in head and neck squamous cell carcinoma.
Rettig EM; Bishop JA; Agrawal N; Chung CH; Sharma R; Zamuner F; Li RJ; Koch WM; Califano JA; Guo T; Gaykalova DA; Fakhry C
Oral Oncol; 2018 Jul; 82():168-175. PubMed ID: 29909892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
